<?xml version="1.0" encoding="UTF-8"?>
<p>
 <italic>Keypoints</italic> . bDMARDs are not associated with worsened outcomes in patients with CHIKV infection. Anti-TNF biological use may reduce symptom duration in chikungunya fever patients.
</p>
